Amsino acquires MedXL to expand prefilled syringe capacity

Amsino International completed the acquisition of MedXL to increase its North American prefilled syringe capacity to over 500 million syringes annually.

“Our supply chain resilience model – backed by increased manufacturing muscle from the North American manufacturing acquisition – positions us to deliver on our promise of quality, continuity, and customer focus.”prnewswire.com

• 1 source
• prnewswire.comAmsino Named Exclusive Flush Syringe Supplier for Mount Sinai Health SystemAmsino InternationalNov 13, 2025

Summarized from public sources; check the original articles before acting on it.